000 04063cam a2200433 i 4500
005 20250918235651.0
008 140714s2013 fluaf b 001 0 eng
020 _a9781439848005 (hardcover : alk. paper)
_cRM618.68
020 _a1439848009 (hardcover : alk. paper)
020 _a9781439848012 (ebook)
020 _a1439848017 (ebook)
039 9 _a201410141551
_bruzini
_y07-14-2014
_zfida
040 _aDNLM/DLC
_beng
_erda
_cDLC
_dBTCTA
_dNLM
_dCDX
_dUKMGB
_dOCLCO
_dYDXCP
_dIXA
_dIUL
_dMMU
_dUKM
_erda
090 _aWW166.C21 2013 9
090 _aWW166
_b.C21 2013 9
245 0 0 _aOcular Drug Delivery Systems :
_bBarriers and Application of Nanoparticulate Systems /
_cedited by Deepak Thassu and Gerald J. Chader.
264 1 _aBoca Raton :
_bCRC Press,
_c© 2013.
264 4 _c© 2013.
300 _axv, 447 pages, [10] pages of plates :
_billustrations (some color) ;
_c24 cm.
336 _atext
_2rdacontent.
337 _aunmediated
_2rdamedia.
338 _avolume
_2rdacarrier.
504 _aIncludes bibliographical references and index.
505 0 0 _g1.
_tNanoparticulate-based therapeutics: an overview /
_rDeepak Thassu, Kris Holt, and Gerald J. Chader --
_g2.
_tEye anatomy, physiology and ocular barriers: basic considerations for drug delivery /
_rGerald J. Chader and Deepak Thassu --
_g3.
_tAnimal models to evaluate nanoparticulate drug delivery systems /
_rVinson M. Wang, Jingsheng Tuo, and Chi-Chao Chan --
_g4.
_tComputer modeling for ocular drug delivery /
_rPaul J. Missel --
_g5.
_tConsiderations for development of ophthalmic nanotechnology-based drugs /
_rBanu S. Zolnik, Sherizaq Baksh, and Nakissa Sadrieh --
_g6.
_tBlood-retinal barrier: the fundamentals /
_rRosa Fernandes, Andreia Gon{u386C}ves, and JosCunha-Vaz --
_g7.
_tBarriers to transscleral drug delivery to the retina /
_rAlexandra Almazan ... [et al.] --
_g8.
_tDrug delivery to the vitreous humor /
_rFrancine Behar-Cohen --
_g9.
_tTransscleral and suprachoroidal drug delivery /
_rDamian E. Berezovsky and Henry Edelhauser --
_g10.
_tProtein drug delivery to retina and choroid /
_rHogwen M. Rivers and Patrick M. Hughes --
_g11.
_tTransscleral drug delivery to the posterior segment of the eye /
_rBernard F. Godley ... [et al.] --
_g12.
_tDrug delivery to the suprachoroidal space /
_rSung Won Cho and Timothy Olsen --
_g13.
_tUse of nanoparticles in the treatment of age-related macular degeneration, glaucoma and other degenerative retinal diseases /
_rMarco A. Zarbin ... [et al.] --
_g14.
_tDrug molecule characteristics and their impact on anterior versus posterior segment drug delivery strategies /
_rKay D. Rittenhouse --
_g15.
_tSurface modulation of nanoparticles /
_rDeepak Thassu and Kris Holt --
_g16.
_tNanoparticles for the treatment of retinal diseases / Amin Famili and Uday B. Kompella --
_g17.
_tGene-based medicine for ocular diseases /
_rShannon M. Conley and Muna I. Naash --
_g18.
_tStealth-type polymeric nanoparticles with encapsulated betamethasone phosphate for treatment of intraocular inflammation /
_rTsutomu Sakai, Tsutomu Ishihara, and Megumu Higaki --
_g19.
_tNanotechnology-guided imaging of retinal vascular disease /
_rJoshua R. Trantum, John S. Penn, and Ashwath Jayagopal --
_g20.
_tPhotoresponsive polymers for ocular drug delivery /
_rLaura A. Wells and Heather Sheardown --
_gt21.
_tNanosuspensions in ocular drug delivery systems /
_rHimanshu Bhattacharjee and Sonia Bedi.
650 2 _aEye Diseases
_xdrug therapy.
650 2 _aBlood-Retinal Barrier.
650 2 _aDrug delivery systems
_xmethods.
650 2 _aNanoparticles
_xtherapeutic use.
700 1 _aThassu, Deepak,
_eeditor.
700 1 _aChader, Gerald,
_eeditor.
776 0 8 _iOnline version:
_tOcular drug delivery systems.
_dBoca Raton : CRC Press/Taylor & Francis, 2013
_z9781439848012
_w(OCoLC)817933183
907 _a.b15951340
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kWW166.C21 2013 9
914 _avtls003565018
991 _aFakulti Farmasi, KKL
998 _ad
_b2014-01-07
_cm
_da
_feng
_gflu
_y0
_z.b15951340
999 _c574514
_d574514